Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The ELISA is an immunological assay commonly used for the detection of antibodies, antigens, proteins and glycoproteins which are prone to present in the biological samples. Some of examples includes the diagnosis of HIV infection, pregnancy test and measurement of cytokines or soluble receptors in the biological liquid samples. ELISA assay are generally carried out in 96 well plates which allows multiple samples to be measured in a single experiment. These plates must be special absorbant plates like immune plates for ensuring the sticking of antigen or antibody to the surface. Every ELISA measures a specific antigen and kits for a variety of antigens are widely available.
The United States enzyme-linked immunosorbent assay market is witnessing lucrative growth during the forecast period of 2019 - 2028. The ELISA based on the principle that specific antibodies bind the target and detect the presence and quality of antigen binding. In order to increase the sensitivity along with precision of the assay, the plate must be coated with antibodies whose having high affinity. The dynamic factors such as increasing cases of infectious diseases is propelling growth of United States enzyme-linked immunosorbent assay market. Furthermore, continuous development of innovative and novel products by key players is also boosting growth of United States enzyme-linked immunosorbent assay market. However, presence of other immunoassay techniques is hindering growth of United States enzyme-linked immunosorbent assay market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Enzyme-linked immunosorbent assay market. In addition, complete analysis of changes on Enzyme-linked immunosorbent assay expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19.
The United States enzyme-linked immunosorbent assay market is bifurcated into type, application and end user.
Based on type, the United States enzyme-linked immunosorbent assay market is segmented into the sandwich ELSIA, indirect ELSIA, direct ELSIA, competitive ELSIA. In which indirect ELSIA is estimated to dominate the market in 2020. The indirect ELISA test is also referred as two step ELISA which includes two binding process of primary antibody and labelled secondary antibody. The primary antibody is incubated with antigen followed by the incubation with the secondary antibody.
Based on application, the United States enzyme-linked immunosorbent assay market is bifurcated into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. In which drug monitoring and pharmaceuticals is also contributing to the growth of market in 2020. The ELISA technique allows the identification and quantification of previously known proteins to be ascertained by immunological means. The key to ELISA is linking of antibody to the enzyme which is capable of catalyzing a colorimetric or chemiluminescent reactions.
Based on end user, the United States enzyme-linked immunosorbent assay market is categorised into the hospital and diagnostic centres, research laboratories and other. In which hospital and diagnostic centres are likely to dominate the market in 2020. The increasing flow of patients in hospital and diagnostic centres is propelling growth of enzyme-linked immunosorbent assay market. The rising number of hospitals and diagnostic centres is also boosting growth of enzyme-linked immunosorbent assay market. The rising demand for quality testing is also refuelling growth of enzyme -linked immunosorbent assay market.
The major key players of Enzyme-linked immunosorbent assay market are Alpco, Abcam Plc, Agilent Technologies Inc., BD Biosciences, Bio-Rad Laboratories Inc., Biolegend Inc., Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd., Merck Kgaa, Mercodia Ab, Ortho-Clinical Diagnostics Inc., Perkinelmer Inc., Qiagen Nv, R&D Systems Inc., Shenzen Yhlo Biotech Co. Ltd., Thermo Fischer Scientific Inc., Zeus Scientific, Inc. and Biomérieux Sa among others.
February 2021: The Thermo Fisher Scientific Inc., acquired the private point of care molecular diagnostic company named as Mesa Biotech.
February 2020: The Becton Dickinson and Co. reported a collaborated with Babson Diagnostic for bringing lab quality, little volume blood assortment to retail drug stores.
March 2018: BARD1 Life sciences, The U.S. based science research company is expected the commercialization of BARD1-Ovarian blood based ELSIA test for distinguishing ovarian diseases in the beginning phase.
January 2018: The Eagle Biosciences Inc., presented a novel unblemished FGF23 ELISA unit test which is the 96 well sandwich ELISA examination. It is estimated as full-length dynamic type of human Intact FGF23 utilized for the discovery of mineral bone disorder, chronic kidney disorder, chronic kidney disease and hyperphosphatemia.
The report analyses the Enzyme-linked immunosorbent assay market based on type, application and end user. The various type of ELISA test covered in the report are sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. By application, the market is segmented into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. Based on end user, the market is segmented into the hospital and diagnostic centre, research laboratories and other. The report also analyses the impact of COVID-19 on the Enzyme-linked immunosorbent assay market and it is analyses that the COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19. The report also covers the major key players operating in the market.
Why to buy this report
